MBIO News and Press, Mustang Bio Inc. From 09/30/21

WORCESTER, Mass., Sept. 30, 2021 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, so...

WORCESTER, Mass., Sept. 28, 2021 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, so...

Mustang Bio remains underfollowed despite having several therapies that have the potential to be major breakthroughs in some of the most notorious and hard-to-treat diseases. MBIO's share price is near the 52-week lows despite the company completing milestones and a few bullish cataly...

WORCESTER, Mass., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, so...

Are These 3 Reddit Penny Stocks on Your Watchlist? Over the past year, the popularity of Reddit penny stocks has increased dramatically. If you’re unfamiliar, this is a group of penny stocks that are frequently mentioned across the social media website Reddit. And, if you...

WORCESTER, Mass., Aug. 16, 2021 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, sol...

The exclusively licensed platform has potential application for any tumor target Preclinical development to continue at Mayo Clinic Mustang to file IND upon identification of a lead CAR construct WORCESTER, Mass., Aug. 12, 2021 (GLOBE NEWSWIRE) -- Mustang...

bluebird bio (BLUE -25.0%) has lost nearly a quarter of its market cap after the company announced that the FDA placed a clinical hold on studies of elivaldogene autotemcel designed to target cerebral adrenoleukodystrophy (CALD). Elivaldogene autotemcel also known as (eli-cel, Lenti-D) is a g...

3 Hot Penny Stocks to Watch This Week With a new week in August upon us, which penny stocks are investors watching? Well, to understand this we have to take into consideration what’s going on in the world. Right now, this includes the highly positive jobs report that came out las...

Mustang Bio (NASDAQ:MBIO) announces that the European Medicines Agency (EMA) has granted Priority Medicines (“PRIME”) designation to MB-107 for the treatment of X-linked severe combined immunodeficiency (“XSCID”) in newly diagnosed infants, also known as bubble boy...